CD4 and breast carcinoma: Taken together, the METABRIC data analyses provided clinical evidence for the functional relationship between ING4 and GZMB in the basal subtype of breast cancer and supported the conclusion that the decrease in GzmB+CD4+ T cells in the TME contributes to metastatic tumor progression of ING4-deficient breast cancer.